New Delhi: The contribution of non-communicable diseases (NCDs) as the top causes of death in India has risen to a staggering 64.9 per cent as compared to communicable diseases, maternal and other causes that dropped to 25 per cent, Apollo Hospitals Group said on Wednesday. The healthcare major also unveiled a report on the ‘Health … Read more
New Delhi, February 26, 2021: Biopharmaceutical company Takeda India, (part of the Takeda Pharmaceutical Company Limited) on Friday launched an application for the management of patients with rare lysosomal storage disorders. The application named ‘XPERT EASE‘ is developed for the exclusive use of healthcare professionals to address awareness-related challenges and enable an efficient digital ecosystem … Read more
Secondly, the FDA has yet to greenlight any of these treatments. What’s more, some early trials of mRNA therapies have suffered major stumbling blocks on the road to market approval. In January, CureVac reported disappointing results in a clinical trial of its new mRNA-based drug for prostate cancer. The company’s CV9014 drug did … Read more
As India continues to battle the coronavirus pandemic, the government has issued guidelines on prevention and treatment of co-infections of Covid-19 with other seasonal epidemic-prone diseases like dengue, malaria, seasonal influenza, and chikungunya, observed every year during this time. The government has also said that the co-infections can not only present as a diagnostic dilemma … Read more